Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators. Marchioli R, et al. Among authors: valagussa f. Circulation. 2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2. Circulation. 2002. PMID: 11997274 Clinical Trial.
Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Levantesi G, et al. Among authors: valagussa f. J Am Coll Cardiol. 2005 Jul 19;46(2):277-83. doi: 10.1016/j.jacc.2005.03.062. J Am Coll Cardiol. 2005. PMID: 16022955 Free article. Clinical Trial.
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Macchia A, Levantesi G, Franzosi MG, Geraci E, Maggioni AP, Marfisi R, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Macchia A, et al. Among authors: valagussa f. Eur J Heart Fail. 2005 Aug;7(5):904-9. doi: 10.1016/j.ejheart.2005.04.008. Eur J Heart Fail. 2005. PMID: 16087142 Free article.
[Determinants of late-onset heart failure in myocardial infarction survivors: GISSI Prevenzione trial results].
Macchia A, Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Investigadores del estudio Grupo Italiano para el Estudio de la Supervivencia en el Infarto de Miocardio Prevenzione. Macchia A, et al. Among authors: valagussa f. Rev Esp Cardiol. 2005 Nov;58(11):1266-72. Rev Esp Cardiol. 2005. PMID: 16324579 Free article. Spanish.
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.
Avanzini F, Alli C, Boccanelli A, Chieffo C, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione investigators. Avanzini F, et al. Among authors: valagussa f. J Hypertens. 2006 Dec;24(12):2377-85. doi: 10.1097/01.hjh.0000251897.40002.bf. J Hypertens. 2006. PMID: 17082719
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
Franzosi MG, Brunetti M, Marchioli R, Marfisi RM, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators. Franzosi MG, et al. Among authors: valagussa f. Pharmacoeconomics. 2001;19(4):411-20. doi: 10.2165/00019053-200119040-00008. Pharmacoeconomics. 2001. PMID: 11383757
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring.
Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione Investigators. Macchia A, et al. Among authors: valagussa f. Am Heart J. 2006 Mar;151(3):754.e7-754.e17. doi: 10.1016/j.ahj.2005.10.023. Am Heart J. 2006. PMID: 16504647
GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design.
Giannuzzi P, Temporelli PL, Maggioni AP, Ceci V, Chieffo C, Gattone M, Griffo R, Marchioli R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F; GOSPEL. Giannuzzi P, et al. Among authors: valagussa f. Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):555-61. doi: 10.1097/01.hjr.0000186623.60486.26. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 16319545 Clinical Trial.
62 results